This week please join author Christian Ruff and Associate Editor Andrea Russo as they discuss the article "Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial." For the episode transcript, visit: <a href= "https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.ahajournals.org%2Fdo%2F10.1161%2Fpodcast.20250804.510827&data=05%7C02%7Claura.dennison%40wolterskluwer.com%7C04b30c54bd914a8f991708ddd37d6723%7C8ac76c91e7f141ffa89c3553b2da2c17%7C0%7C0%7C638899257894710522%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=tmBXMziQmRTFnDwVa7HoCnJRHB8ahNyY2xQLxJCd%2FQo%3D&reserved=0"> https://www.ahajournals.org/do/10.1161/podcast.20250804.510827</a>

Circulation August 12, 2025 Issue

Each 15-minute podcast begins with an overview of the issue's contents and main take-home messages for busy clinicians on the run. This is followed by a deep dive into a featured article of particular clinical significance: views will be heard from both author and editor teams for a "behind the scenes" look at the publication. Expect a fun, highly conversational and clinically-focused session each week!